Literature DB >> 17414080

Economic implications of an evidence-based sepsis protocol: can we improve outcomes and lower costs?

Andrew F Shorr1, Scott T Micek, William L Jackson, Marin H Kollef.   

Abstract

OBJECTIVE: To determine the financial impact of a sepsis protocol designed for use in the emergency department.
DESIGN: Retrospective analysis of a before-after study testing the implications of sepsis protocol.
SETTING: Academic, tertiary care hospital in the United States. PATIENTS: Persons with septic shock presenting to the emergency department.
INTERVENTIONS: A multifaceted protocol developed from recent scientific literature on sepsis and the Surviving Sepsis Campaign. The protocol emphasized identification of septic patients, aggressive fluid resuscitation, timely antibiotic administration, and appropriateness of antibiotics, along with other adjunctive, supportive measures in sepsis care.
MEASUREMENTS AND MAIN RESULTS: We compared patients treated before the protocol with those cared for after the protocol was implemented. Overall hospital costs represented the primary end point, whereas hospital length of stay served as a secondary end point. All hospital costs were calculated based on charges after conversion to costs based on department-specific cost-to-charge ratios. We also attempted to measure the independent impact of the protocol on costs through linear regression. We conducted a sensitivity analysis assessing these end points in the subgroup of subjects who survived their hospitalization. The total cohort included 120 subjects (evenly divided into the before and after cohorts) with a mean age of 64.7 +/- 18.2 yrs and median Acute Physiology and Chronic Health Evaluation II score of 22.5 +/- 8.3. There were more survivors following the protocol's adoption (70.0% vs. 51.7%, p = .040). Median total costs were significantly lower with use of the protocol ($16,103 vs. $21,985, p = .008). The length of stay was also on average 5 days less among the postintervention population (p = .023). A Cox proportional hazard model indicated that the protocol was independently associated with less per-patient cost. Restricting the analysis to only survivors did not appreciably change our observations.
CONCLUSIONS: Use of a sepsis protocol can result not only in improved mortality but also in substantial savings for institutions and third party payers. Broader implementation of sepsis treatment protocols represents a potential means for enhancing resource use while containing costs.

Entities:  

Mesh:

Year:  2007        PMID: 17414080     DOI: 10.1097/01.CCM.0000261886.65063.CC

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  33 in total

1.  Peripherally inserted central catheters are equivalent to centrally inserted catheters in intensive care unit patients for central venous pressure monitoring.

Authors:  Heath E Latham; Scott T Rawson; Timothy T Dwyer; Chirag C Patel; Jo A Wick; Steven Q Simpson
Journal:  J Clin Monit Comput       Date:  2012-04       Impact factor: 2.502

2.  Merinoff symposium 2010: sepsis--an international call to action.

Authors:  Christopher J Czura
Journal:  Mol Med       Date:  2010 May-Jun       Impact factor: 6.354

3.  Early and adequate antibiotic therapy in the treatment of severe sepsis and septic shock.

Authors:  John D Dickinson; Marin H Kollef
Journal:  Curr Infect Dis Rep       Date:  2011-10       Impact factor: 3.725

Review 4.  Sepsis pathophysiology and anesthetic consideration.

Authors:  Koichi Yuki; Naoka Murakami
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2015

Review 5.  Economics of Early Warning Scores for identifying clinical deterioration-a systematic review.

Authors:  A Murphy; J Cronin; R Whelan; F J Drummond; E Savage; J Hegarty
Journal:  Ir J Med Sci       Date:  2017-06-03       Impact factor: 1.568

6.  Implementation of modified early-goal directed therapy for sepsis in the emergency center of a comprehensive cancer center.

Authors:  Katy M Hanzelka; Sai-Ching J Yeung; Gary Chisholm; Kelly Willis Merriman; Susan Gaeta; Imrana Malik; Terry W Rice
Journal:  Support Care Cancer       Date:  2012-09-07       Impact factor: 3.603

7.  Evaluation of a machine learning algorithm for up to 48-hour advance prediction of sepsis using six vital signs.

Authors:  Christopher Barton; Uli Chettipally; Yifan Zhou; Zirui Jiang; Anna Lynn-Palevsky; Sidney Le; Jacob Calvert; Ritankar Das
Journal:  Comput Biol Med       Date:  2019-04-24       Impact factor: 4.589

8.  Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy.

Authors:  Graeme N Forrest; Mary-Claire Roghmann; Latoya S Toombs; Jennifer K Johnson; Elizabeth Weekes; Durry P Lincalis; Richard A Venezia
Journal:  Antimicrob Agents Chemother       Date:  2008-07-28       Impact factor: 5.191

9.  Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study.

Authors:  Marya D Zilberberg; Marin H Kollef; Heather Arnold; Andrew Labelle; Scott T Micek; Smita Kothari; Andrew F Shorr
Journal:  BMC Infect Dis       Date:  2010-06-03       Impact factor: 3.090

10.  Quality and performance improvement in critical care.

Authors:  Lakshmi P Chelluri
Journal:  Indian J Crit Care Med       Date:  2008-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.